Neuro MR: protocols.
Clinical MRI depends on a symbiosis between MR physics and clinical requirements. The imaging solutions are based on a balance between the "palette" of available image contrasts derived from nuclear spin physics and tissue biophysics, and clinical determinants such as the anticipated pathology and efficient use of imaging time. Imaging is therefore optimized to maximize diagnostic sensitivity and specificity through the development of protocols organized along the lines of major disease categories. In the other part of this two-part review, the primary determinants of image contrast, including T1, T2, and T2*, were highlighted. The development of pulse sequences designed to optimize each of these image contrasts was discussed and the impact of technological innovation (parallel imaging and high-field systems) on the manner in which these sequences could be modified to improve clinical efficacy was further emphasized. The scope of that discussion was broadened to include the application of: 1) water diffusion imaging used primarily for detection of pathologies that restrict the free movement of water in the tissues and for defining fiber tracts in the brain; 2) the intravenous administration of exogenous contrast agents (gadolinium-diethylene triamine pentaacetic acid [GdDTPA]) for assessment of blood-brain-barrier (BBB) defects and brain blood flow; and 3) MR spectroscopy (MRS) for assessment of brain metabolites. The goal of this part is to discuss how these acquisitions are combined into specific protocols that can effectively detect and characterize, or in keeping with our artistic analogy, "paint" each of the major diseases affecting the central nervous system (CNS). This work concludes with a discussion of image artifacts and pitfalls in image interpretation, which, in spite our best efforts to minimize or eliminate them, continue to occur. Much of the ensuing discussion is based on our own institutional experience. Protocols, therefore, do not necessarily match those from other institutions due to variability in clinical emphasis, MR instruments, and available software. An attempt was made to focus on basic clinical sequences that are available on most modern MR systems, with protocols employing generally accepted clinical imaging philosophies.
Mikulis
David J
DJ
Department of Medical Imaging, The University Health Network, The Toronto Western Hospital, Toronto, ON, Canada. mikulis@uhnres.utoronto.ca
Roberts
Timothy P L
TP
D000792:Angiography / Q000379:methods; D001921:Brain / Q000473:pathology*; D001932:Brain Neoplasms / Q000175:diagnosis / Q000473:pathology*; D003287:Contrast Media / Q000494:pharmacology*; D017352:Echo-Planar Imaging / Q000379:methods; D004827:Epilepsy / Q000175:diagnosis / Q000473:pathology*; D005682:Gadolinium / Q000494:pharmacology; D006801:Humans; D007090:Image Interpretation, Computer-Assisted / Q000379:methods; D008279:Magnetic Resonance Imaging / Q000379:methods*; D009462:Neurology / Q000379:methods*; D011522:Protons; D013997:Time Factors
D003287:Contrast Media; D011522:Protons; D005682:Gadolinium